Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) KSC

6,020.00

+40(+0.67%)

Updated at December 05 11:26AM

Currency In KRW

Valuation

Market Cap217.75B
Enterprise Value387.48B
P/E Ratio8.67
PEG Ratio1.82
Price/Sales Ratio0.15
Price/Book Ratio0.41
Enterprise/Revenue0.26
Enterprise/EBITDA3.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.02
Operating Margin0.01

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue1.64T
Revenue/Share41,018.76
Gross Profit299.3B
EBITDA44.63B
Net Income40.48B
Diluted EPS1,010.12

Balance Sheet

Total Cash194.59B
Total Cash/Share4,932.17
Total Debt288.27B
Total Debt/Equity0.5
Current Ratio1.53
Book Value Per Share15,714.94

Price History

52-Week Change10.33
52-Week High6,900
52-Week Low5,110
Moving Average 50 Days5,830.6
Moving Average 200 Days5,790.85

Statistics

Average Volume143,295
Shares Outstanding39.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield1.67
Payout Ratio0.14
Last Split FactorN/A
Last Split DateN/A